These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38418639)

  • 1. Evaluation of changes in macular structures after subthreshold micropulse laser therapy on chronic central serous chorioretinopathy.
    Liu L; Xu Q; Song X; Zhao Y; Zhang Y; Qu Y
    Lasers Med Sci; 2024 Feb; 39(1):83. PubMed ID: 38418639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy.
    Altınel MG; Acikalin B; Gunes H; Demir G
    Lasers Med Sci; 2021 Sep; 36(7):1505-1514. PubMed ID: 33409750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy.
    Uzlu D; Erdöl H; Kola M; Özbay AD
    Lasers Med Sci; 2021 Jul; 36(5):981-988. PubMed ID: 32812130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Feenstra HMA; Hahn LC; van Rijssen TJ; Tsonaka R; Breukink MB; Keunen JEE; Peters PJH; Dijkman G; Souied EH; MacLaren RE; Querques G; Downes SM; Fauser S; Hoyng CB; van Dijk EHC; Boon CJF
    Retina; 2022 Apr; 42(4):721-729. PubMed ID: 34864802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nondamaging subthreshold laser therapy in patients with chronic central serous chorioretinopathy.
    Lee SH; Lee J; Kim M; Roh YJ
    Graefes Arch Clin Exp Ophthalmol; 2024 May; 262(5):1433-1442. PubMed ID: 38010518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China.
    Zhao T; Li J; Wang Y; Guo X; Sun Y
    Ann Med; 2023 Dec; 55(1):2227424. PubMed ID: 37382371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy.
    Malik KJ; Sampat KM; Mansouri A; Steiner JN; Glaser BM
    Retina; 2015 Mar; 35(3):532-6. PubMed ID: 25127050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety between subthreshold micropulse laser, standard-fluence and low-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Altinel MG; Kanra AY; Totuk OMG; Ardagil A; Turkmen OF
    J Fr Ophtalmol; 2021 Apr; 44(4):499-508. PubMed ID: 33642060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy.
    Schworm B; Siedlecki J; Keidel LF; Herold TR; Luft N; Priglinger SG
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3271-3281. PubMed ID: 34110452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Grzybowski A
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2299-2306. PubMed ID: 28831603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy.
    Scholz P; Ersoy L; Boon CJ; Fauser S
    Ophthalmologica; 2015; 234(4):189-94. PubMed ID: 26406874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data.
    Subhi Y; Bjerager J; Boon CJF; van Dijk EHC
    Acta Ophthalmol; 2022 Feb; 100(1):89-95. PubMed ID: 33998168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological parameters predicting subthreshold micropulse laser effectiveness in central serous chorioretinopathy.
    Kiraly P; Smrekar J; Jaki Mekjavić P
    Lasers Med Sci; 2022 Oct; 37(8):3129-3136. PubMed ID: 35579726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Dijkman G; Peters PJH; Tsonaka R; Keunen JEE; MacLaren RE; Hoyng CB; Downes SM; Fauser S; Boon CJF
    Acta Ophthalmol; 2021 Nov; 99(7):805-811. PubMed ID: 33565230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological and anatomical outcomes of subthreshold micropulse laser therapy in chronic central serous chorioretinopathy.
    Kayhan B; Demir N; Sevincli S; Sonmez M
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103221. PubMed ID: 36464217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
    Scholz P; Altay L; Fauser S
    Eye (Lond); 2016 Oct; 30(10):1371-1377. PubMed ID: 27391938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.
    Torres-Costa S; Penas S; Cerqueira AR; Brandão E; Carneiro Â; Rocha-Sousa A; Falcão-Reis F
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102235. PubMed ID: 33631379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.
    Kim JY; Park HS; Kim SY
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2129-35. PubMed ID: 25717024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.